Comparison of the 6-minute walk test with established parameters for assessment of cardiopulmonary capacity in adults with complex congenital cardiac disease

Cardiology in the Young

Volumn 15, Issue 4, 2005, Pages 385-390

  Niedeggen, Andreas ^a   Skobel, Erik ^a   Haager, Philipp ^a   Lepper, Wolfgang ^a   Mühler, Eberhard ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Brain natriuretic peptide; Exercise capacity; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; OXYGEN;

ADULT; ANAEROBIC METABOLISM; ARTERIAL TRUNK; ARTICLE; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; EXERCISE TEST; FALLOT TETRALOGY; FEMALE; GREAT VESSELS TRANSPOSITION; HEART PERFORMANCE; HEART SINGLE VENTRICLE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INTERMETHOD COMPARISON; MALE; OXYGEN CONSUMPTION; PROTEIN BLOOD LEVEL; PULMONARY VALVE ATRESIA; QUANTITATIVE ANALYSIS; RESPIRATORY FUNCTION; STANDARDIZATION; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS; WALKING;

ADULT; ANAEROBIC THRESHOLD; EXERCISE TEST; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; TIME FACTORS; WALKING;

EID: 25844470976     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1047951105000818     Document Type: Article

References (32)

1. Bolger A, Coats A, Gatzoulis M. Congenital heart disease: the original heart failure syndrome. Eur Heart J 2003; 24: 970-976.
2. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. First of two parts. N Engl J Med 2000; 342: 256-263.
3. Webb CL, Jenkins KJ, Karpawich PP, et al. Collaborative care for adults with congenital heart disease. Circulation 2002; 105: 2318-2323.
4. Fredriksen PM, Chen A, Veldtman G, Hechter S, Therrien J, Webb G. Exercise capacity in adult patients with congenitally corrected transposition of the great arteries. Heart 2001; 85: 191-195.
5. Fredriksen P, Veldtman G, Hechter S, et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol 2001; 87: 310-314.
6. Fritsch J, Winter U, Kaemmerer H, Hilger H. Cardiopulmonary capacity of patients with congenital heart defects in childhood, adolescence and adulthood. Z Kardiol 1994; 83: 131-139.
7. Hechter S, Webb G, Fredriksen P, et al. Cardiopulmonary exercise performance in adult survivors of Mustard procedure. Cardiol Young 2001; 11: 407-414.
8. Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002; 40: 718.
9. Kruger S, Hoffmann R, Graf J, Janssens U, Hanrath P. Brain natriuretic peptide: Diagnostische und prognostische Bedeutung bei chronischer Herzinsuffizienz. Med Klin 2003; 98: 562-567.
10. Mulders F, Kromer E, Griese D, et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 2004; 134: 442-449.
11. Sinha A, Filzmaier K, Breithardt O, et al. Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patient with heart failure. Am J Cardiol 2003; 91: 755-758.
12. Tsutamoto T, Wada A, Madea K. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction - comparison with plasma angiotensin II and endothelin-1. Eur J Echocardiogr 1999; 20: 1799-1807.
13. Tulevski I, Groenink M, van der Wall E, et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001; 86: 27-30.
14. Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002; 106: 92-99.
15. Hjortdal VE, Stenbog EV, Ravn HB, et al. Neurohormonal activation late after cavopulmonary connection. Heart 2000; 83: 439-443.
16. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119: 256-270.
17. Enright PL. The six-minute walk test. Respir Care 2003; 48: 783-785.
18. Garofano R, Barst R. Exercise testing in children with primary pulmonary hypertension. Pediatr Cardiol 1999; 20: 61-64.
19. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993; 270: 1702-1707.
20. Haass M, Zugck C, Kübler W. The 6 minute walk test: a cost effective alternative to cardiopulmonary exercise testing in patients with congestive heart failure? Z Kardiol 2000; 89: 72-80.
21. Kuster G, Tanner H, Printzen G, Suter T, Mohacsi P, Hess O. B-type natriuretic peptide for diagnosis and treatment of congestive heart failure. Schweiz Med Wochenschr 2003; 133: 623-628.
22. Fischer Y, Filzmaier K, Stiegler S. Evaluation of a new rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 2001; 47: 591-594.
23. Logeart D, Saudubray C, Beyne P, et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 2002; 40: 1794-1800.
24. Beaver W, Wassermann K, Whipp B. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60: 2020-2027.
25. Weber K, Janicki J, McElroy P. Determination of aerobic capacity and the severity of chronic cardiac and circulatory failure. Circulation 1987; 76: VI40-VI45.
26. ATS Statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
27. Helbing WA, Bosch HG, Maliepaard C, et al. Comparison of echocardiographic methods with magnetic resonance imaging for assessment of right ventricular function in children. Am J Cardiol 1995; 76: 589-594.
28. Wilson NJ, Neutze JM, Rutland MD, Ramage MC. Transthoracic echocardiography for right ventricular function late after the Mustard operation. Am Heart J 1996; 131: 360-367.
29. Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type nacriuretic peptide (BNP) testing. Eur Heart J 2003; 24: 1710-1718.
30. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132: 919-923.
31. Zugck C, Kruger C, Durr S, et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 2000; 21: 540-549.
32. Pinna DG, Opasich C, Mazza A, Tangenti A, Maestri R, Sanarico M. Reproducibility of the six-minute walking test in chronic heart failure patients. Stat Med 2000; 19: 3087-3094.